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Available online 8 January 2016The mechanisms that govern speciﬁcation of various cell types that constitute vertebrate heart are not fully un-
derstood. Whilst most studies of heart development have utilised the mouse embryo, we have used an alterna-
tive model, embryos of the frog Xenopus laevis, which permits direct experimental manipulation of a non-
essential heart. We show that in this model pluripotent animal cap explants injected with cardiogenic factor
GATA4 mRNA express pan-myocardial as well as ventricular and proepicardial markers. We found that cardiac
cell fate diversiﬁcation, as assessed by ventricular and proepicardial markers, critically depends on tissue integ-
rity, as it is disrupted by dissociation but can be fully restored by inhibition of the BMP pathway and partially
by Dkk-1. Ventricular and proepicardial cell fates can also be restored in reaggregated GATA4-expressing cells
upon transplantation into a host embryo. The competence of the host embryo to induce ventricular and
proepicardial markers gradually decreases with the age of the transplant and is lost by the onset of myocardial
differentiation at the late tailbud stage (st. 28). The inﬂuence of the host on the transplant was not limited to di-
versiﬁcation of cardiac cell fates, but also included induction of growth and rhythmic beating, resulting in gener-
ation of a secondary heart-like structure. Our results additionally show that efﬁcient generation of secondary
heart requires normal axial patterning of the host embryo. Furthermore, secondary hearts can be induced in a
wide range of locations within the host, arguing that the host embryo provides a permissive environment for de-
velopment of cardiac patterning, growth and physiological maturation. Our results have implications for a major
goal of cardiac regenerative medicine, differentiation of ventricular myocardium.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Heart is the ﬁrst functional organ in developing vertebrate embryos.
It forms through an overlapping sequence of speciﬁcation, differentia-
tion and morphogenesis steps. Much of what is known about heart de-
velopment was derived from genetic analyses in the mouse. However,
one limitation of the mouse model derives from the essential role of
the heart during embryonic development aswell as exquisite sensitivity
of the heart to systemic perturbations. Complementary models for
studying heart development that compensate for these limitations are
zebraﬁsh and Xenopus embryos, as their development until later stages
does not require a functional heart.
Xenopus heart is composed of three chambers, one ventricle and two
atria, and is evolutionarily located between the two-chambered ﬁsh
heart and the four-chambered amniote heart (Warkman and Krieg,
2007). These morphological differences are not restrictive because
heart development is governed by a core of evolutionally conserved
transcription factors (Gessert and Kuhl, 2009; Olson, 2006). The conser-
vation between Xenopus and mouse heart development extends to. This is an open access article underexpression of cardiac transcription factors in First and Second Heart
Fields (Gessert and Kuhl, 2009).
Heart mesoderm speciﬁcation in Xenopus is thought to occur during
gastrulation (Sater and Jacobson, 1989) and cardiac precursors subse-
quently migrate towards the anterior end, moving on laterally to fuse
on the ventral midline to form a delta-shaped sheet fromwhich a linear
heart tubewill be generated (Kolker et al., 2000). At this stage the heart
tube expresses pan-myocardial markers myl7 (synonym MLC2;
(Latinkic et al., 2004)), and myh6 (synonym MHCα (Logan and
Mohun, 1993; Mohun et al., 2000)) and is located along the
anteroventral region behind the cement gland along the embryonic A-
P axis (Mohun et al., 2000). The expression of myl7 and myh6 indicate
the onset of cardiac differentiation. At stage 35 the linear heart tube
changes its anterior–posterior axis direction because the posterior side
(presumptive atrium and sinus venous) moves dorsally, more closely
to the anterior region and the heart tubemoves anticlockwise in a spiral
motion in the process known as heart looping. Consequently, the out-
ﬂow tract (OFT, positioned anteriorly) moves medially and the conus
(positioned posteriorly) relocates to the right side of the embryo. Dur-
ing heart chamber formation (stage 39–40) the atrium is located dorsal-
ly compared to the ventricle and at the same time the development of
ventricular trabeculae and valves occurs.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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from the proepicardium which develops in the posterior limits of the
heart between the sinus venosus and the liver (Manner et al., 2001).
Mesenchymal cells delaminate from epicardium and invade the myo-
cardiumand subepicardial spaces to provide the cardiac vessels and car-
diac ﬁbroblasts. The epicardium is characterised by restricted (but not
epicardial-speciﬁc) expression of transcription factors Wilm's tumour
(WT-1), Pod-1/epicardin (Perez-Pomares et al., 2009; Ratajska et al.,
2008) and Tbx18 (Cai et al., 2008; Jahr et al., 2008) and is involved in
the proliferation of the embryonic myocardium (Manner et al., 2001;
Perez-Pomares et al., 2009; Smith and Bader, 2007).
The chambermyocardium is generated from a pool of rapidly prolif-
erating cardiac precursor cells. As the precursors differentiate into
cardiomyocytes proliferation slows down but their size increases.
There is the inverse relationship between the proliferation and differen-
tiation: in Xenopus, cyclin-dependent kinase inhibitor p27Xic is re-
quired for cardiac differentiation (Movassagh and Philpott, 2008).
Regionalisation of the developing heart is manifested by the restrict-
ed expression of genes such as myl3, irx4 and nppa. myl3 (synonym
MLC1v) is a regionalised myocardial marker that is expressed after
heart looping (stage 36) in the ventricle; outside of the heartmyl3 is dy-
namically expressed in somites and hyoid muscles (Smith et al., 2005).
Iroquois 4 (irx4) homeodomain transcription factor is involved in ven-
tricular development, and its expression in Xenopus becomes restricted
to the ventricle within the heart after stage 39 (Garriock et al., 2001;
Smith et al., 2005). Despite the number of genes known to be regionally
expressed within the differentiated myocardium in Xenopus, still there
are no speciﬁc atrial markers at the time when ventricular differentia-
tion is ongoing. A well described atrial marker in all vertebrates, atrial
natriuretic factor (nppa), is expressed throughout the developing myo-
cardium from stage 32, and only at stage 49 its expression is exclusively
seen in the atrium (Small and Krieg, 2000).
To investigate speciﬁcation of cardiac cell types (diversiﬁcation of
cardiac fates)we used Xenopuspluripotent blastula stage animal cap ex-
plants. Expression of GATA4 in animal cap explants has been known to
induce pan-myocardial cardiac differentiationmarkermyl7 and beating
tissue (Latinkic et al., 2003), but speciﬁcation of other cardiac fates has
not been reported. Here we show, using GATA4 as a trigger of
cardiogenesis in animal cap explants, that ventricular and proepicardial
(VP) cell fates are induced in a process that requires tissue integrity.
Practical limit for culturing animal cap explants is until around st. 40,
well before nppa becomes restricted to the presumptive atria, and has
precluded us from directly establishing atrial cardiomyocyte fate. In-
stead we have relied on indirect method afforded by double whole-
mount in situ hybridisation (double WMISH) with a panmyocardial
(e.g. myl7) and a ventricular marker such as myl3 and considering a
myl7+/myl3− area as atrial. In GATA4-expressing explants whose in-
tegrity has been disrupted by dissociation, VP fates can be rescued by in-
hibition of BMP signalling. Cultured animal cap explants, however, are
not an optimal model to study cardiac morphogenesis and growth. To
examine these aspects of heart development we used an alternative
assay in which GATA4-injected dissociated animal cap explants
transplanted into host embryo develop a secondary ‘heart’,
characterised by cardiac cell diversiﬁcation, growth, beating and limited
morphogenesis. Using this assay we show that VP fates can be speciﬁed
in GATA4-induced cardiac precursors by the signal(s) provided by the
host embryo until the onset of cardiac differentiation.
2. Materials and methods
2.1. Xenopus embryos, microinjection and explants
Xenopus embryos were obtained, injected and cultured in 10% Nor-
mal Amphibian Medium (NAM; 110 mM NaCl, 2 mM KCl, 1 mM
Ca(NO3)2, 1 mM MgSO4, 0.1 mM EDTA, 1 mM NaHCO3) (Sive et al.,
2000). Animal pole explants were excised on agarose-coated dishes(1% agarose in dH2O) at stage 8.5–9 and cultured in 75% NAM until
the indicated stage. For dissociation, animal cap explants were cut in
95% Ca2+/Mg2+-free saline medium (CMFM; 88 mM NaCl, 1 mM KCl,
2.4 mM NaHO3, 7.5 mM Tris–HCl pH 7.6) and 5% of 75%NAM. Twenty
ﬁve explants were transferred to a 1.5ml tube and dissociated by gentle
agitation in CMFM, 0.1% Bovine Serum Albovine (BSA, Sigma). The dis-
sociated cells were centrifuged at 1000 rpm for 1 min and CMFM, 0.1%
BSA was replaced with CMFM, 0.5 mM CaCl2. The cells were left for
3 h at 19–21 °C. The reaggregated cells (reaggregates) were transferred
to agarose-coated dishes containing 75%NAM and gentamicine (25 mg/
ml, Sigma-Aldrich) and cultured at 19–21 °C. Dexamethasone (2 μM;
Sigma), dissolved in ethanol, was added at the stages indicated. Trans-
genic frog line Cardiac actin-GFP has been described (Latinkic et al.,
2002). Heart ﬁeld explants were excised from the embryos at stage 20
as previously described (Rafﬁn et al., 2000). Dissociation of heart ﬁeld
explants was carried out using CMFMwith 0.1% BSA and reaggregation
was carried out by adding 0.5mMCaCl2 to CMFM. Heart Fieldwere cul-
tured in 0.75×NAMuntil required stage. Axis perturbation by UV expo-
sure was performed as previously described (Sive et al., 2000). UV-
treated embryos were scored using the dorsoanterior index (DAI)
(Sive et al., 2000). Irradiated embryos with DAI lower than 2 were cho-
sen for further experiments (Sive et al., 2000).
Synthetic capped RNA was synthesised as described (Sive et al.,
2000). The amounts injected were: 1 ng Gata4-GR (Afouda et al.,
2005; Latinkic et al., 2003), 1 ng Dkk1 (Glinka et al., 1998) and 1 ng
tBr (Graff et al., 1994). mRNAs were coinjected together with rhoda-
mine–dextran (20 mg/ml) and dextran–biotin (25 mg/ml) as lineage
tracer in a ﬁnal concentration of 10%.
Dissociated and reaggregated explantswere transplanted at stage 20
in the ventral region of Xenopus host embryos at the same stage. Before
transplantation reaggregated explantswere cut to 0.03mm in size using
a 10mmgraticule (Tonbridge, Kent, England) placed under the agarose
dish as a guide. Transplanted embryos were cultured in 0.75 × NAM
with gentamicine (25 mg/ml, Sigma-Aldrich). Green Fluorescent Pro-
tein (GFP) presencewas detected using a LeicaMZ16F Fluorescence Ste-
reomicroscope with a GFP ﬁlter (GFP2: excitation 480/40 nm, emission
510 nm).
2.2. Whole mount in situ hybridization
Whole-mount in situ hybridization (WMISH)was carried out by the
method described (Sive et al., 2000), using the digoxigenin or ﬂuoresce-
in (Roche)-labelled antisense riboprobes. Templates for synthesising
myl3 (Smith et al., 2005), myl7 (Latinkic et al., 2004) and tnni3
(Drysdale et al., 1994) have been described. Template for tbx18 was
generated by cloning a PCR product obtained with primers used for
RT-PCR analysis (see below) into pGemTEasy (Promega); SalI was
used for linearization and T7 polymerase to synthesise antisense probe.
2.3. Immunoﬂuorescence
Immunoﬂuorescence was carried out as described (Kolker et al.,
2000), using mouse anti-chicken tropomyosin monoclonal primary
antibody (CH1; Developmental Studies Hybridoma Bank) −1:50
and Goatα-mouse Alexa Fluo 488 (Invitrogen)−1:500 as secondary
antibody. For confocal analysis, samples were dehydrated in metha-
nol, and cleared with benzyl alcohol/benzyl benzoate (Fisher
Scientiﬁc).
2.4. RT-PCR
Total RNA was isolated from samples using the acid guanidinium
thiocyanate-phenol-chloroform method (Chomczynski and Sacchi,
1987). 20–25 animal cap explants, 3 reaggregates, 5 HF explants or 5
control embryos were used per sample, and cDNA synthesised using
MMLV-RT (Invitrogen, UK) and random hexamers according to
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merase (Promega, UK) with the following cycling conditions: 95 °C for
30 s, 58 °C for 30 s, 72 °C for 30 s. Primer sequences: irx4 (GenBank
No. NM_001096735) F: tgcagctttgggtgtctatg, irx4 R:
atggccagcatgatcttctc; myl3 (AY289206) F: tgggacagaatccaaccaat, R:
tgaatggtgttcctgtgcat; myl7 (AY219706) F: tgtatcgaccaaaaccgtga, R:
attggggtcacagcaaacat; odc1 (NM_001086698) F:
gccattgtgaagactctctccatt, R: ttcgggtgattccttgccac; tbx18 (EB736397) F:
tgtttccagccatgagagtg, R: gagagatggctccaaaatgc; wt1 (BC170513) F:
atcagtgtctcagcgccttt, R: gagaggtctgttggctgagg.
3. Results
3.1. GATA4 induces cardiac cell diversiﬁcation in intact animal cap explants
To study themechanisms involved in cardiac cell fate diversiﬁcation
we used animal cap explants from blastula stage Xenopus embryos
injected with GATA4 mRNA. Previous experiments showed that ex-
plants injectedwithGATA4mRNAexpressed the pan-myocardialmark-
er myl7 (Latinkic et al., 2003). To test if the cardiac tissue induced by
GATA4 included diversiﬁcation of different cell types, we ﬁrst examined
the expression of the ventricular marker myl3 at stage 39–40, when it
becomes restricted to the developing ventricle within the heart
(Smith et al., 2005). Whole mount in situ hybridisation (WMISH) anal-
ysis showed regional expression of myl3 in the majority of explants
(Fig. 1A, C; 75%, n= 50). In addition, explants were analysed using dou-
ble WMISH for expression of the cardiac troponin (tnni3) and myl3
markers (Fig. 1F, H). The heart of the control whole embryos at stage
39 showed an overlapping expression between tnni3 and myl3 in the
ventricle region and tnni3 expression alone in the region morphologi-
cally corresponding to the atria (Fig 1I, J). We could not verify directly
atrial cell fate identity since no speciﬁc markers are available in Xenopus
for the stages of development that were focus of this study (see Intro-
duction). GATA4-injected AC explants showed similar gene expression
pattern to embryonic hearts, with areas of overlapping expression be-
tween tnni3 and myl3 (36%) and regions of tnni3 expression alone
seen in 13% of explants (Fig. 1F, H; n = 55). Similar result has beenFig. 1. GATA4 induces the expression of ventricular and proepicardial markers in animal cap e
GATA4 (75%, n = 50) using WMISH analysis for the expression of myl3. (B, C) Close-up of a
E) Lateral and ventral views of a myl3 expression in control embryo (stage 39). (F–H) An
myocardial marker tnni3 and ventricular marker myl3 (36% (n = 55), 13% showed tnni3 exp
show a region of overlapping expression (black arrowheads) and region expressing tnni3 a
GATA4 or co-injected with GATA4 and Dkk-1 mRNA showed the expression of the ventricula
same stage. A representative experiment out of 3 repeats is shown. a, atrium; ih, interhyoid mfound in GATA4 injected AC explants analysed using double-WMISH
for the expression of myl3 and another pan-myocardial marker, myl7
(41% (n = 41) data not shown). Induction of ventricular cell fate in
AC explants by GATA4 was also conﬁrmed by the expression of another
marker, irx4 (Fig. 1K; irx4 has prominent extracardiac expression and is
expressed at a much lower level thanmyl3 (Garriock et al., 2001), mak-
ing myl3 our marker of choice for ventricular cell fate). Together with
the ventricular cell fate, we also found that GATA4 induced
proepicardial cell fate differentiation by the expression of the
proepicardial markers tbx18 and wt1 (Figs. 1K and 2C). Even though
these markers are not epicardial-speciﬁc, the expression of both
markers detected byRT-PCR in explants and the expression of tbx18 de-
tected byWMISH in GATA4-injected cells in vivo (see below) is consis-
tent with proepicardial cell fate. GATA4 was shown to be required for
normal development of the proepicardium in the mouse embryo
(Watt et al., 2004) and ourﬁnding that GATA4 is also sufﬁcient to induce
proepicardial cell fate in pluripotent AC explants conﬁrms and extends
this result.
3.2. GATA4-induced ventricular and proepicardial cell fates require tissue
integrity
To gain insights into the mechanisms of cardiac cell diversiﬁcation
induced by GATA4 in AC explants we dissociated them and subsequent-
ly reaggregated (thus creating “reaggregates”). This procedure disrupts
cell–cell contacts and any heterogeneity, or patterning that was
established by this developmental stage, such as the anterior–posterior
axis (Sokol and Melton, 1991). We found that GATA4 induced cardiac
differentiation in reaggregates, as shown by expression of myl7, but
the expression of the ventricular and proepicardial markers was lost
(Fig. 2). Thisﬁndingoffered anopportunity to study themechanisms in-
volved in the establishment of cardiac cell type diversiﬁcation. As ven-
tricular tissue is located anteriorly within the heart, we have
attempted to anteriorise reaggregates by using secreted Wnt antago-
nist, Dkk-1. Co-expression of GATA4 andDkk-1 in reaggregateswas suf-
ﬁcient to restore the expression of myl3, but not of proepicardial
markers (Fig. 2B). When analysed by WMISH, 50% of GATA4 and Dkk-xplants. (A) Ventricular gene expression is induced in animal cap explants injected with
nimal cap explants shown in (A); black arrowheads are indicating myl3 expression. (D,
imal caps injected with GATA4 showed incompletely overlapping expression of pan-
ression only). Similarly to the heart of control embryos (I, J), GATA4 injected AC explants
lone (white arrowhead). (K) RT-PCR analysis in AC explants at stage 40 injected with
r (myl3 and irx4) and proepicardial (tbx18) markers as in sibling control embryos at the
uscle of the jaw; v, ventricle. The scale bar corresponds to 100 μm.
Fig. 2.Cardiac cell diversiﬁcation is lost in dissociated and reaggregated animal cap explants but can be restored by blocking BMP signalling. (A) Restricted cardiac gene expression is lost in
GATA4 injected explants dissociated and reaggregated. Inhibition of BMP signalling through dominant-negative BMP type I receptor (tBr) restores ventricular and proepicardial gene
expression in GATA4 co-injected reaggregated explants. (B). Ventricular gene expression (myl3) is partially restored in explants also co-injected with GATA4 and Dkk-1 mRNA.
(C) The second proepicardial marker, WT1, shows the same pattern of expression as Tbx18 in intact (Fig. 1K) and reaggregated animal cap explants expressing GATA4, GATA4 and
Dkk-1 or GATA4 and tBr. AC, Animal Caps; G4, GATA4; R, dissociated and reaggregated animal caps. RT-PCR was performed at stage 40 according to control embryos. A representative
experiment is shown out of 3 (A, B) or 2 (C).
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We have initially considered the importance of spatially restricted de-
livery of Dkk-1 by conjugating Dkk-1 expressing AC explants with
GATA4-injected reaggregates, and we observed the same result as
with uniform expression of Dkk-1 (data not shown), suggesting that
speciﬁcation of ventricular fate does not require anterior–posterior gra-
dient ofWnt signalling, and that instead anterior tissue character is suf-
ﬁcient. Additional anteriorising treatment, through inhibition of BMP
signalling via dominant-negative BMP type I receptor (Graff et al.,
1994), resulted in restoration of both ventricular and proepicardial
gene expression in GATA4-injected reagreggates (Fig. 2A). Thus, in
this model cardiac cell fate diversiﬁcation is driven by GATA4 in a pro-
cess that critically requires tissue integrity and anterior character. In ad-
dition, BMP pathway inhibition may have an instructive role in this
process.
3.3. GATA4 injected reaggregates generate a secondary heart-like structure
when transplanted into a host embryo
We have shown that antagonism of Wnt and BMP signalling can re-
store aspects of cardiac cell diversiﬁcation in GATA4-injected reaggre-
gates. Another potential means of inducing a more complete process
of cardiogenesis in GATA4 reaggregates is by transplantation into a
host embryo, as reported by Ariizumi et al. for Activin-treated reaggre-
gates [44]. In our modiﬁcation of the assay, we used a cell-autonomous
trigger of cardiogenesis, GATA4,with fewer additional effects (i.e., lower
induced cellular complexity) compared to Activin. GATA4-injected re-
aggregates were transplanted at stage 20 in ventro-posterior region of
sibling embryos at the same stage. To allow real time imaging of
cardiogenesis of transplanted reaggregates (“transplants”) we used
transplants derived from transgenic embryos expressing GFP in striated
muscle under control of cardiac actin promoter, CAG-GFP [46]. Previous
work has established that GATA4 induces cardiac but not skeletal mus-
cle in animal cap explants (Latinkic et al., 2003), thus allowing us to un-
ambiguously interpret GFP activity as a readout of cardiac
differentiation. At stage 39–40 100% of transplants showed GFP activity
and 46% (n=220)were beating (Fig. 3A, F). In addition, doubleWMISH
conﬁrmed that the transplants expressed ventricular marker myl3 andproepicardial marker tbx18 when analysed at stage 40 (Fig. 3 — 65% of
the reaggregates show patterned myl3 and tbx18 expression; n =
30). Cardiac tissue within transplants underwent rudimentarymorpho-
genesis, as evidenced by the formation of tube-like structures (Fig. S1).
Transplants, independently from the structure gained at stage 39–40,
showed beating activity. Thus, transplantation of GATA4-injected reag-
gregates into host embryos results in formation of secondary heart-like
(SH) structures, with patterned ventricular and proepicardial gene ex-
pression (Fig. 3), frequent beating and with aspects of cardiac
morphogenesis.
3.4. Embryonic axes of the host embryo are required for the development of
secondary heart-like structure
We showed that GATA4-injected reaggregates transplanted at stage
20 into isochronic host embryos developed a secondary heart-like struc-
ture (Fig. 3). To begin characterisation of the nature of the host-
transplant interaction that results in the development of SH, we ﬁrst
assessed the role of axial patterning of the host. We transplanted
GATA4 injected reaggregates into UV-ventralised host embryoswith se-
vere dorso-anterior truncations. Transplants present in UV-treated
hosts showed evidence of cardiogenesis when analysed at stage 35
(CAG-GFP activity; Fig. 4A, B). This was conﬁrmed usingWMISH analy-
sis for the expression of myl7, showing that cardiac induction triggered
by GATA4 in AC explants was maintained in UV-ventralised hosts
(Fig. 4D — 35% n = 65). More signiﬁcantly, transplants placed into
UV-treated hosts did not beat and also failed to express ventricular
marker myl3 when analysed at stage 39 (Fig. 4D′). In addition, the size
of heart tissue in transplants appeared to be signiﬁcantly smaller in
UV-treated hosts, an observation that was followed up below (Fig. 8D
and Fig. S3). These results suggested that normal axial patterning of
the host is required for the formation of the secondary heart and that
the host does not merely provide trophic support. Closer analysis of ex-
perimentswith control hosts (R20H20) showed that the axis deﬁned by
the relative position of ventricular, non-ventricular myocardial and
proepicardial tissuewithin SHs (Fig. 3) did not show consistent correla-
tion with embryonic axes of the host embryo (data not shown). There-
fore, the ventricular and proepicardial cell fates are not speciﬁed by a
Fig. 3. Ventricular and proepicardial gene expression is restored in reaggregated animal cap explants expressing GATA4 upon transplantation into host embryos. (A–F) Dissociated and
reaggregated GATA4 injected explants (CAG-GFP) were transplanted at stage 20 into host (CAG-GFP) at the same stage. GFP expression was recorded at stage 39. (C, F) lineage tracing
(rhodamine dextran) of transplants in D and E. (G, H) Transplants were analysed for the expression of myl7 and myl3. 48% of transplants (n = 45) showed patterned gene expression
with regions of overlapping expression between myl7 and myl3 corresponding to the ventricle and regions expressing myl7 alone. 30% of transplants expressed only myl7, and in 17%
there was a complete overlap between myl7 and myl3. (G′, H′) Close-up of transplants shown in G and H. Black head arrow shows overlapping gene expression and white head arrow
shows region of myl7 expression alone. (I, J) 65% of transplants (n = 30) express both Tbx18 and myl7. (I′,J′) Close-up of transplants shown in I and J. h, heart; ih, interhyoid muscle
of the jaw; p, proepicardium; v, ventricle. The scale bar corresponds to 100 μm.
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er, our results argue in favour of an essential permissive role of the pri-
mary embryonic axis in speciﬁcation of ventricular and proepicardial
cell fates.
3.5. Ventro-lateral embryonic areas permit secondary heart formation
The ability to generate a SH from GATA4-injected reaggregates de-
pends on the host embryo. To identify the region or regions in the
host capable of supporting the development of a SH, we transplanted
GATA4 injected reaggregates (CAG-GFP) at stage 20 in different loca-
tions of the host at the same stage (Fig. 5). Transplants placed in the
head region of the hosts were not beating, despite being capable of car-
diac differentiation (50%, n= 20, Fig. 5B). In contrast, transplants in the
lateral and caudal region of the host were beating (Fig. 5C,E) similarly to
control reaggregates transplanted in the ventral region of the host
(Fig. 3). GATA4 injected reaggregates transplanted in the dorsal side of
the host lacked cardiac gene expression when analysed at stage 37
(100%; n = 20) with respect to control transplants at the same stage(Fig. 6B). When the same set of transplants was analysed at stage 40
they showed cardiac gene expression (50% n = 20) but did not beat
(Fig. 6C). Dorsal transplants were also analysed using double WMISH
for the expression of myl7 and myl3 and a small region of overlapping
expression between thesemarkers was seen (Fig. 6D′) in contrast to ex-
pression pattern found in control reaggregates (Fig. 3). Therefore, dorsal
transplants of GATA-4 induced cells showed delayed and less effective
cardiac differentiation and cell fate diversiﬁcation.
The delay in cardiomyocyte markers expression in reaggregates
transplanted into the dorsal region of the host might have been caused
by Wnt/β-catenin signalling, which is known to be high at the dorsal
midline and to be a negative regulator of cardiogenesis (Schneider and
Mercola, 2001; Tzahor and Lassar, 2001). To test this scenario we used
reaggregates co-injected withmRNAs encoding GATA4 andWnt antag-
onist Dkk-1 and transplanted them at stage 20 in the dorsal side of the
host and in the ventral side of the host as control transplants (Fig. 6E–
H′). When dorsal transplants were analysed at stage 37, consistent car-
diac gene expression was found (90% n = 20) as indicated by the ex-
pression of GFP (Fig. 6F, F′). These transplants were also analysed by
Fig. 4. Secondary heart formation is lost inUV-ventralised hosts. (A, B) GATA4 injected reaggreagates (CAG-GFP)were transplanted at stage 20 in control (A, A′) or UV-treated hosts (B, B′)
at the same stage. Transplantswere viable (A′, B′) andwere also positive for GFP expression in both control andUV-transplants analysed at stage 39. (C, D) Double-WMISH analysis for the
expression of myl7 andmyl3 indicated that whilst control transplants showed patterned expression of bothmyl7 andmyl3markers (C), transplants in UV-hosts (D) only expressedmyl7
expression (white arrowhead). (C′, D′). Highermagniﬁcation of transplants shown inC andD. Region of overlap betweenmyl3 andmyl7 (purple) is indicated by black arrowhead. h, heart;
ih, interhyoid muscle of the jaw; t, transplant; v, ventricle. The scale bar corresponds to 100 μm.
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H′). The results showed a region of overlapping expression between
myl7 and myl3 and a region positive for myl7 only (Fig. 6H, H′), similar
to the one seen in control transplants. Despite showing robust and time-
ly cardiac differentiation, dorsal transplants injected with GATA4 and
Dkk-1 did not beat, similar to GATA4-injected reaggregates
transplanted in the head and in the dorsal region of the host embryos.
These embryonic regions apparently restrict the development of physi-
ological maturation of the myocardium.
3.6. Secondary heart can be formed until just prior to cardiac differentiation
To deﬁne the time window within which GATA-4 injected reaggre-
gates can generate a SH,we performed a series of transplantation exper-
iments using reaggregates of different developmental stages at the time
of transplantation and host embryos at stage 20 (Fig. 7). Analysis of
these transplants showed that all developed SHs that were capable of
beating, with the exception of those transplanted at stage 28 (Fig. 7A,
D). In addition, stage 28 transplants had a different morphology when
compared to younger transplants, as theywere not compact but instead
contained loosely arranged cells, some ofwhichweremigrating into the
host embryo (Fig. 7D, D′). In contrast to reaggregates transplanted atstage 20 and 24, which showed expression of both myl7 and myl3
markers (Fig. 7E, F), reaggregates transplanted at stage 28 showed the
expression of myl7 only (Fig. 8G). Thus, the competence of GATA4-
expressing transplants to generate a secondary heart in which cardiac
cell diversiﬁcation has occurred exists before stage 20 and gradually de-
clines until it is completely lost by stage 28 (Fig. 7). Stage 28 transplants
behaved like GATA4 injected reaggregates cultured in vitro. These re-
sults suggest that cardiac precursors can receive the signals required
for SH formation within a relatively broad time window.
To test whether our ﬁndings obtained with GATA4-expressing ani-
mal cap explants might be applicable to native cardiac precursors, we
investigated ventricular and proepicardial cell fate speciﬁcation in
heart ﬁeld (HF) explants. The HFs are able to grow and differentiate au-
tonomously in culture and have the capacity to generate a looped beat-
ing structure (Rafﬁn et al., 2000). WMISH analysis for the expression of
myl7 and myl3 showed a region of overlapping expression of myl7 and
myl3 as well as a region expressing myl7 alone (Fig. S2) similarly to
what was found in control embryos and control transplants at the
same stage. RT-PCR analysis of HFs at stage 40 conﬁrmed the expression
of irx4 and tbx18. In contrast, heartﬁeld explants thatwere subjected to
dissociation/reaggregation expressed pan-myocardial marker myl7
only, suggesting that tissue integrity is essential for ventricular and
Fig. 5. Host shows broad spatial competence for the development of the secondary heart. (A) GATA4 injected reaggregates (CAG-GFP) were transplanted at stage 20 into host embryos
(CAG-GFP) at the same stage in a number of different regions, as indicated by the number. (B, B′) 51% of transplants in the head showed GFP expression but did not beat (n = 20). (C–
E′) Transplants in the lateral (position 5) and the caudal side (position 4) of host embryos developed beating SH as control ventral transplants. Transplant were all analysed at stage
39. (B, E′) lineage tracing (rhodamine dextran) of transplants whose cardiac GFP activity is shown in B′ and E, respectively. h, heart.
Fig. 6. Dorsal GATA4-expressing transplants show a Dkk-1 sensitive delay of cardiogenesis. (A, A′) Control transplants of GATA4-injected reaggregates (CAG-GFP) showed cardiac
differentiation by GFP expression at stage 37 as indicated by the arrows. (B, B′) In contrast, transplants placed in the dorsal side of the host (position 6 in Fig. 5A) were negative for
GFP expression at stage 37 (100%; n = 20), but 50% were positive after stage 39 (C, C′). No beating activity was detected in these reaggregates. (D, D′) Double-WMISH showed that
20% (n = 94) of dorsal transplants express myl7 alone (white arrowhead) and only a small group of cells express both myl7 and myl3 (black arrowhead). (E–F′) Both control and
dorsal transplants of reaggregates (CAG-GFP) co-injected with GATA4 and Dkk-1 showed evidence of cardiac differentiation (GFP activity) at stage 37. (G, G′) Cardiac expression is
maintained in dorsal transplants at stage 40. Beating activity was never detected in dorsal transplants. (H, H′) Double WMISH shows overlapping expression between myl7 and myl3
(black arrowhead) and regions of myl7 expression alone (white arrowhead) in 35% of dorsal transplants (n = 84; the remaining transplants were negative for cardiac gene
expression). a, atrium; ih, interhyoid muscle of the jaw; t, transplant; v, ventricle. The scale bar corresponds to 100 μm.
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Fig. 7.Competence to generate a secondary heart ismaintained until the onset of cardiac differentiation. GATA4-injected animal cap reaggregates (CAG-GFP)were transplanted at stage 13
(A, A′), 24 (B, B′), 26 (C, C′) and 28 (D, D′) in the ventral side of host embryos at stage 20 (CAG-GFP) and were analysed at stage 39–40 for cardiac GFP expression and for lineage tracing
(rhodamine-dextran). (E–G′) Patterned expression ofmyl7 andmyl3was found in reaggregates transplanted at stage 20 and 24. Overlapping expression is indicated by black arrowheads
and myl7-only expression by white arrowheads. (H) Summary of frequency of GFP expression and beating activity. The capacity to generate a beating structure declines with the
increasing age of the transplants. (I) Data summarised the number of embryos positive to the gene expression of myl7 and myl3 in double WMISH. h, heart; t, transplant. The scale bar
corresponds to 100 μm.
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(Fig. S2). Dissociation of HF explants reproducibly led to a decrease in
cardiac differentiation (Fig. S2), suggesting that tissue integrity is im-
portant for the maintenance of speciﬁed cardiac fate. This is in contrast
with dissociated AC explants expressing exogenous cell-autonomous
cell fate speciﬁer GATA4, which presumably makes cardiogenesis
under those conditions less sensitive to tissue disruption. Taken togeth-
er, our ﬁndings suggest that in embryos ventricular and proepicardial
cell fates are not stably speciﬁed at stage 20, many hours after cardiac
induction and that this aspect of cardiogenesis is reproduced in a pro-
cess regulated by GATA4 in AC explants.
3.7. Growth of secondary hearts
Secondary hearts showed an enhancement in cardiogenesis that is
clearly lost in transplants at stage 28 and in transplants placed in UV-
treated hosts.We documented the extent of cardiac differentiation (rel-
ative size of cardiac area) in secondary hearts (R20/H20) compared to
R20/H20UV and R28/H20 transplants. Real-time analysis was per-
formed using CAG-GFP transplants in both UV treated and wild-type
hosts at stage 39. The CAG-GFP positive areawithin rhodamine–dextran
labelled transplants was assessed by image analysis, which showed that
R20/H20-UV transplants consistently have smaller CAG-GFP positive
(cardiac) area when compared with R20/H20 control transplants
(Fig. S3). This conclusion was conﬁrmed when embryos were analysed
using double-WMISH for the expression of myl7/myl3 (Fig. 8). Lineage
tracing conﬁrmed that the transplant size was comparable in all threetreatment groups, however, the area occupied by cardiac tissue within
the transplants was greater in R20/H20 samples compared to R20/
H20UV and R28/H20 (Fig. 8). Three-dimensional shape and variable lo-
cation of transplants made it difﬁcult to quantify this effect and have
limited our analysis to qualitative assessment. Nonetheless, our obser-
vations suggest that cardiac tissue expands in SHs and that the growth
may be regulated in a similar manner as cardiac cell diversiﬁcation in
the heart. The loss of competence of transplanted stage 28 cardiac pre-
cursors to respond to the signals from the host, and the disruption of
those signals in UV-treated hosts, prevent growth of cardiac tissue in
transplants and the formation of SH.4. Discussion
In this study we have developed an experimental model to investi-
gate cell fate diversiﬁcation during vertebrate heart development. This
model is based on pluripotent animal pole cells from Xenopus embryos
in which cardiogenesis was triggered by the expression of GATA4.
Whereas induction of expression of pan-myocardial markers is a cell-
autonomous process, speciﬁcation of ventricular and proepicardial
fates by GATA4 requires cell–cell communication and can be restored
in reaggregated explants by inhibition of BMP signalling. Cardiac cell di-
versiﬁcation can also be restored in GATA4-expressing animal pole cells
by transplantation into a host embryo. Transplants in addition generat-
ed a secondary heart-like structure that developed rhythmical beating,
underwent rudimentary morphogenesis and grew, all features of heart
Fig. 8.Growth of secondary hearts is dependent on the host embryo. Transplants in samples analysed by double-WMISH formyl7 andmyl3 at stage 39were visualised by lineage tracing
(pink-light red colour). (A, B) Examples of control transplants (R20H20; GATA-4 injected reaggregates transplanted at stage 20 into host embryos at the same stage) show that cardiac
tissue occupies a substantial part of the transplant. In contrast, cardiac tissue in (C) R28H20 and (D) R20H20UV (UV-ventralised hosts) transplants occupies a much smaller area
(arrows). (D) Inside view of a dissected sample is presented to better show cardiac tissue (myl7, pointed by an arrow). Lineage trace that is visible from the outside is outlined. The
scale bar corresponds to 100 μm. All images except the insert in (C) (showing the heart dissected from control embryo at stage 39) are at the same magniﬁcation. At least 5 samples
were analysed for each treatment, with comparable results.
39S. Caporilli, B.V. Latinkic / Mechanisms of Development 139 (2016) 31–41development that do not commonly occur in cultured animal cap ex-
plants in vitro injected with GATA4.
4.1. Inhibition of BMP is sufﬁcient to specify ventricular and proepicardial
(VP) fates during GATA4-induced cardiogenesis
Loss of VP cell fates caused by dissociation of GATA4-expressing ex-
plants implies that the required factor was either secreted and present
at the time of dissociation, or that its production requires speciﬁc spatial
arrangement of cells in the explant that is lost by dissociation. Our evi-
dence suggested that an extracellular gradient is not required, since uni-
form expression of a cell-autonomous reagent, dominant-negative BMP
receptor I, is capable of restoring VP cell fates. Inhibition of BMP signal-
ling leads to anteriorisation of animal pole explants and it is possible
that this plays a role in inducing ventricular cell fate, which is anterior
within the heart, in GATA4-expressing reaggregates. Consistent with
the view that BMP inhibition acts to anteriorise cardiac tissue,
anteriorisation viaWnt antagonist Dkk-1 can rescue ventricular speciﬁ-
cation in GATA4-expressing reaggregates. However, our data shows
that BMP inhibition rescues proepicardial cell fate as well, arguing that
BMP signalling has an additional instructive role in cardiac cell fate
diversiﬁcation.
Animal pole ectodermal explants are known to contain BMP ligands,
and their removal by dissociation (Godsave and Slack, 1989; Grunz and
Tacke, 1989) or blocking by secreted antagonist Noggin (Lamb et al.,
1993) induces neural cell fate. Here we have shown that expression of
GATA4 in intact animal caps induces panmyocardial, ventricular and
proepicardial cell fates, suggesting that endogenous BMP is at least per-
missive for the process. We have also shown that inhibition of BMP sig-
nalling via truncated BMP receptor can restore VPmarker expression indissociated GATA4-expressing animal cap explants. This apparently
paradoxical result indicates that perhaps endogenousBMP and/or tissue
integrity are required to generate a BMP antagonist which acts at a later
stage, or that the effect is quantitative (requirement for a greater level of
BMP inhibition than can be afforded by AC dispersal).
Our ﬁndings are in agreement with studies on zebraﬁsh embryos
that have shown that inhibition of the BMP pathway is required in the
cardiac ﬁeld and that it favours ventricular cell fate speciﬁcation (de
Pater et al., 2012; Marques and Yelon, 2009).
4.2. Broad ventro-lateral areas of a host embryo support secondary heart
development
The secondary heart formation assay we used in the current study is
a modiﬁcation of the assay described by Ariizumi and colleagues, in
which dissociated and reaggregated cells were treated with Activin
and transplanted into host embryo at stage 20 (Ariizumi et al., 2003).
Activin is a well-known mesoderm (Asashima et al., 1990; Green
et al., 1990; Smith et al., 1990) and cardiac tissue inducer (Logan and
Mohun, 1993). As GATA4 acts downstream of Activin/nodal signalling
we used it as a simpler model for cardiogenesis. We found that
GATA4-injected reaggregates transplanted into host embryos displayed
beating and expression of ventricular tissue (myl3+/myl7+) adjacent to
a presumptive atrial compartment (myl3−/myl7+; Fig. 3). The SH also
expressed proepicardial marker tbx18 demonstrating that a further
heart cell diversiﬁcation has occurred (Fig. 3). In addition, we docu-
mented growth (Fig. 8) and aspects of cardiac morphogenesis (Fig. S1)
of SHs. All these attributes of SHs critically depend on the host embryo,
which provides broad permissive regions, ventrolateral and caudal,
where the beating SH can develop (Fig. 5). There is no obvious cellular
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of the host contribute a signal, or signals, which direct SH formation
from transplanted cardiac precursors.
In contrast, head and dorsal midline did not support SH formation.
Dorsal transplants showed a delay in expression of cardiac markers
and did not beat (Fig. 6). Dorsal midline region is regulated by the ex-
pression of Wnt signals which have been shown to repress
cardiogenesis in the chick neural tube (Tzahor and Lassar, 2001). In
Xenopus, activation of Wnt/β-catenin pathway during gastrulation has
no effect on cardiogenesis, while the same pathway blocks
cardiogenesis if activated after cardiac speciﬁcation and before the
onset of cardiac differentiation (Samuel and Latinkic, 2009). Our results
provide evidence that the delay of cardiac differentiation in dorsal
transplants is mediated by Wnt/β-catenin pathway, as it is relieved by
coexpression of GATA4 and Wnt antagonist Dkk-1. GATA4 and Dkk-1
co-injected transplants showed cardiac gene expression from stage 37
as in control transplants (Fig. 6). In these experiments Dkk-1 is presum-
ably acting by protecting the transplants from the inhibitory activity of
Wnt pathway.
4.3. Embryonic axes of the host are required for secondary heart
development
The host does not merely provide trophic signals for the develop-
ment of cardiac precursors present in the transplants. Transplants
placed in UV-treated host express pan-myocardial marker myl7 but
not ventricular marker myl3 (Fig. 4D) and do not grow (Fig. 8). Thus,
transplants placed into UV-treated hosts behave as if they developed
in vitro, in culture (Fig. 2A). How could embryonic axes be involved in
SH formation? Since broad range of embryonic regions supports devel-
opment of SH, we believe that it is unlikely that axial structures are di-
rectly involved. The host most likely provides a signal or signals that
are permissive for the formation of the SH. Retinoids are known to reg-
ulate multiple aspects of anterio-posterior patterning, including heart
development (Xavier-Neto et al., 2015), and could be involved in medi-
ating the permissive signal that we have identiﬁed. Of interest, inhibi-
tion of retinoic acid signalling, together with BMP pathway inhibition
by Noggin, promotes development of ventricular cardiomyocytes from
differentiating human Embryonic Stem cells, whereas BMP inhibition
together with retinoic acid treatment encourages atrial myocyte devel-
opment (Zhang et al., 2011). In our work wewere limited by the lack of
an atrial-speciﬁc marker, and it is possible that cardiac tissue observed
in transplants placed in UV-treated hosts represented atrial, rather
than pan-myocardial fate. This scenario would be consistent with
higher level of retinoic acid signalling in posteriorised UV-treated
embryos.
4.4. Capacity to generate a secondary heart is lost by the onset of cardiac
differentiation
The capacity of GATA4-expressing transplants to develop a SH is ex-
tended after the end of gastrulation to the post-neurula stages (Fig. 7).
However, it decreases at the beginning of the cardiac differentiation
and it is lost just before the linear heart tube stage (stage 28; Fig. 7).
The reaggregates transplanted at stage 28 did not beat when analysed
at stage 40 (Fig. 4). Instead of a compact structure that forms from con-
trol (stage 20) transplants, stage 28 transplants were looser with evi-
dence of extensive cell migration into the host embryo (Fig. 4). The
loss of capacity to generate a SH is likely to be an intrinsic property of
stage 28 GATA4-expressing transplants, and is reminiscent of heart
ﬁeld restriction, in which heart ﬁeld cells that are competent to form
the heart lose this capacity at stage 28 (Sater and Jacobson, 1990). The
relatively broad time windowwithin which SH can be speciﬁed implies
plasticity of cardiac precursors to the signal(s) which must be acting
during that period.4.5. Xenopus explants as a model to study heart organogenesis
The current challenge in directed cardiac differentiation is to pro-
duce relatively pure populations of deﬁned and mature cardiac cells,
as commonly used protocols usually yield a non-speciﬁc mixture of im-
mature cardiomyocytes (Burridge et al., 2012; Vidarsson et al., 2010).
Here we have shown that ventricular and proepicardial cell fates can
be speciﬁed by inhibition of BMP signalling from panmyocardial-fated
precursors, and that cardiac precursors retain plasticity to be induced
to organise a secondary heart until the onset of cardiac differentiation.
Together with prior work that has shown self-assembly of a functional
secondary heart from induced animal pole ectodermal cells (Ariizumi
et al., 2003; Kinoshita et al., 2010), these studies establish Xenopus em-
bryo as a model to investigate cardiac cell diversiﬁcation and organo-
genesis, that complements existing models.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.mod.2016.01.001.
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